From: Using qualitative synthesis to explore heterogeneity of complex interventions
 | Recommendations (1-21) for interventions drawn from qualitative review on patient's perspectives [20]sub-divided by WHO type of adherence risk factor [21] | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | General over arching (1-3) | Therapy (4-6) | HIV-1 status (7, 8) | Patient (9-14) | Healthcare (15-18) | Social circumstances (19-21) | |||||||||||||||
Trialled interventions | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 |
Berrien 2004 | Â | Â | X | X | Â | Â | Â | Â | Â | Â | X | X | X | Â | X | X | X | Â | Â | Â | Â |
Dilorio 2003 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | x | Â | Â | Â | Â | Â |
Fairley 2003 | Â | X | X | X | Â | Â | Â | Â | Â | x | Â | Â | Â | Â | Â | x | Â | X | Â | Â | Â |
Goujard 2003 | Â | x | x | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Levy 2004 | Â | X | Â | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | x | x | X | Â | Â | Â |
Murphy 2002 | Â | X | Â | X | Â | Â | Â | Â | Â | Â | Â | Â | x | Â | Â | Â | x | Â | Â | Â | Â |
Pradier 2003 | Â | x | Â | X | Â | x | X | x | Â | Â | x | X | x | x | X | Â | Â | Â | X | X | Â |
Rathburn 2005 | Â | Â | Â | X | x | Â | Â | Â | Â | Â | x | Â | Â | Â | Â | Â | Â | x | Â | Â | Â |
Rawlings 2003 | Â | Â | Â | x | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | X | X | Â | Â | Â | Â |
Safren 2001 | Â | Â | Â | Â | Â | Â | Â | Â | Â | x | Â | Â | x | Â | x | x | X | Â | Â | Â | Â |
Safren 2003 | Â | Â | Â | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | X | Â | Â | Â | Â | Â |
Samet 2005 | Â | X | X | X | Â | x | Â | X | Â | X | x | Â | X | x | Â | Â | Â | Â | Â | X | Â |
Smith 2003 | Â | Â | Â | X | x | Â | Â | Â | Â | X | Â | X | X | Â | Â | x | Â | Â | X | Â | X |
Tulda 2000 | Â | Â | Â | x | x | X | Â | Â | Â | x | Â | Â | X | Â | Â | Â | X | x | Â | Â | Â |